For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating-and possibly even ...

The San Francisco AIDS Foundation (SFAF) is excited to announce Cycle to Zero, a new 3-day fundraising event benefiting the ...

A new Northwestern Medicine study has uncovered a surprising molecular link between HIV-1 and a protein fragment associated with Alzheimer's disease, according to findings published in the Proceedings ...

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response with just one dose. By combining two immune-boosting adjuvants alum and ...

A federal grant for HIV research is part of $15.7 million the National Institutes for Health awarded to the Wertheim UF Scripps Institute in Jupiter.

LONDON (AP) — Years of American-led investment into AIDS programs has reduced the number of people killed by the disease to the lowest levels seen in more than three decades, and provided life-saving ...

This post was originally published on this site. Led by a team of African researchers, first doses of the novel T cell-inducing GRAdHIVNE1 vaccine candidate have been given. HARARE, ZIMBABWE, ROME, ...

Merck Sharp & Dohme LLC (MSD) has synthesized new N-oxide derivative targeted activator of cell kill (TACK) compounds acting as Gag polyprotein (HIV-1)/protein Pol dimerization inducers reported to be ...

A drug with the potential to drastically curb the HIV epidemic just cleared its first regulatory hurdle. On Wednesday, the Food and Drug Administration approved lenacapavir for the prevention of HIV.